艾伯维公司(ABBV)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ABBV 艾伯维公司

休市中 01-30 16:00:00 EST

223.01

+2.58

+1.17%

盘后222.49

-0.52-0.23%

19:51 EST

最高224.02	最低219.56	成交量662.22万
今开220.51	昨收220.43	日振幅2.03%
总市值3,941亿	流通市值3,932亿	总股本17.67亿
成交额14.72亿	换手率0.38%	流通股本17.63亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ABBV","market":"US","secType":"STK","nameCN":"艾伯维公司","latestPrice":223.01,"timestamp":1769806800000,"preClose":220.43,"halted":0,"volume":6622248,"hourTrading":{"tag":"盘后","latestPrice":222.49,"preClose":223.01,"latestTime":"19:51 EST","volume":1581911,"amount":352780879.30138,"timestamp":1769820693758,"change":-0.52,"changeRate":-0.002332,"amplitude":0.00435},"delay":0,"changeRate":0.011704395953363807,"floatShares":1762950764,"shares":1767384632,"eps":1.320603,"marketStatus":"休市中","change":2.58,"latestTime":"01-30 16:00:00 EST","open":220.51,"high":224.02,"low":219.555,"amount":1471876667.65272,"amplitude":0.020256,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.320603,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1770022800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":220.43,"dividendRate":0.029819,"preHourTrading":{"tag":"盘前","latestPrice":220.5,"preClose":220.43,"latestTime":"09:29 EST","volume":2027,"amount":446430.87859,"timestamp":1769783398091,"change":0.07,"changeRate":0.000318,"amplitude":0.007576},"postHourTrading":{"tag":"盘后","latestPrice":222.49,"preClose":223.01,"latestTime":"19:51 EST","volume":1581911,"amount":352780879.30138,"timestamp":1769820693758,"change":-0.52,"changeRate":-0.002332,"amplitude":0.00435},"volumeRatio":1.0663601235105091,"impliedVol":0.3119,"impliedVolPercentile":0.8048},"requestUrl":"/m/hq/s/ABBV","defaultTab":"news","newsList":[{"id":"2605145750","title":"艾伯维(ABBV.US)利生奇珠单抗新适应症在华获批 用于治疗溃疡性结肠炎","url":"https://stock-news.laohu8.com/highlight/detail?id=2605145750","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605145750?lang=zh_cn&edition=full","pubTime":"2026-01-22 14:31","pubTimestamp":1769063499,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，1月22日，艾伯维宣布利生奇珠单抗在华获批第二项适应症，用于治疗对传统治疗或生物制剂治疗应答不足、失应答或不耐受的中重度活动性溃疡性结肠炎成年患者。IL-23是一种参与炎症过程的细胞因子，被认为与许多慢性免疫介导疾病有关。2025年3月10日，利生奇珠单抗在中国首次获批上市，用于治疗对传统治疗或生物制剂治疗应答不足、失应答或不耐受的中重度活动性克罗恩病成年患者。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1396051.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"艾伯维(ABBV.US)利生奇珠单抗新适应症在华获批 用于治疗溃疡性结肠炎","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4550","LU0211327993.USD","LU1057294990.SGD","LU1496350502.SGD","LU2089984988.USD","LU0965509010.AUD","LU0795875086.SGD","LU1430594728.SGD","LU2237443465.HKD","LU1074936037.SGD","ABBV","LU1496350171.SGD","LU2089283258.USD","LU0320765646.SGD","SG9999011175.SGD","LU0965509101.SGD","LU0820561909.HKD","LU1839511570.USD","LU1093756168.USD","BK4581","IE00BVYPNV92.GBP","IE00B19Z3581.USD","LU0708994859.HKD","LU0689472784.USD","BK4559","LU1718418525.SGD","BK4566","LU0114720955.EUR","LU2023251221.USD","LU0289739343.SGD","IE00BJJMRZ35.SGD","LU1061106388.HKD","SG9999015952.SGD","LU0029864427.USD","LU1732800096.USD","LU0158827948.USD","IE00BVYPNW00.USD","LU1037948541.HKD","LU0058720904.USD","LU0545039389.USD","LU2237443895.HKD","LU1003077747.HKD","LU0965509283.SGD","SG9999001440.SGD","LU2468319806.SGD","LU1551013342.USD","LU0912757837.SGD","LU0310800379.SGD","LU0795875169.SGD","LU2133065610.SGD"],"gpt_icon":0},{"id":"1194878871","title":"艾伯维高管称伊布替尼将面临竞争与价格谈判带来的市场侵蚀——摩根大通医疗会议","url":"https://stock-news.laohu8.com/highlight/detail?id=1194878871","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194878871?lang=zh_cn&edition=full","pubTime":"2026-01-15 01:16","pubTimestamp":1768410985,"startTime":"0","endTime":"0","summary":"在摩根大通医疗健康大会上，艾伯维公司高管坦言，旗下重磅药物伊布替尼（Imbruvica）未来将因市场竞争加剧及医保价格谈判压力，出现一定程度的市场份额侵蚀。\n这一表态反映出生物医药行业当前面临的共同挑战：明星产品在专利保护期后面临仿制药竞争，同时全球范围内医保控费政策日趋严格，企业需在创新投入与利润平衡间寻求新路径。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0472753341.HKD","BK4566","IE00BBT3K403.USD","LU0234572021.USD","IE00B3PB1722.GBP","LU0432979614.USD","LU0795875169.SGD","LU1983299246.USD","LU1037948897.HKD","LU0158827948.USD","LU0211328371.USD","SG9999003800.SGD","IE00BN8TJ469.HKD","LU1989772840.SGD","LU1023059063.AUD","LU1093756168.USD","LU1496350502.SGD","LU0114720955.EUR","LU2129689431.USD","BK4559","LU0661504455.SGD","LU0256863811.USD","LU0965509010.AUD","IE00B19Z3581.USD","LU0124676726.USD","BK4550","LU1003077747.HKD","LU2089283258.USD","LU2089984988.USD","SG9999015945.SGD","BK4585","LU1291159041.SGD","LU0545039389.USD","LU2023251221.USD","LU0289739343.SGD","LU1934455194.USD","LU2129689605.HKD","LU1839511570.USD","IE00B4R5TH58.HKD","LU0943347566.SGD","LU2087621335.USD","BK4534","LU1074936037.SGD","IE0002270589.USD","SG9999015952.SGD","LU1934455863.HKD","IE0002141913.USD","LU0170899867.USD","LU1244550494.USD","BK4533","LU1093756325.SGD","LU1162221912.USD","LU2237443978.SGD","LU0949170772.SGD","LU1267930573.SGD","LU0820561818.USD","ABBV","LU2237443895.HKD","IE00BVYPNW00.USD","LU0310799852.SGD","LU0965508806.USD","LU2112291526.USD","LU1496350171.SGD","LU0057025933.USD","LU0320765646.SGD","LU0689626769.HKD","LU0738911758.USD","LU1989771016.USD","LU1057294990.SGD","LU0198837287.USD","SG9999015986.USD","LU2129689514.USD","LU1037948541.HKD","LU0912757837.SGD","LU1934455277.USD","LU1267930490.SGD","LU1430594728.SGD","LU1732800096.USD","LU1989772923.USD","SG9999011175.SGD","LU2347655156.SGD","IE0009355771.USD","IE00BJJMRZ35.SGD","BK4581","LU0029864427.USD","IE0004445239.USD","LU0069063385.USD","LU2237443465.HKD","LU1585245621.USD","IE00B42XCP33.USD","LU2237443382.USD","IE00BJT1NW94.SGD","IE00BLSP4452.SGD","BK4139","LU0417517546.SGD","LU0122379950.USD","LU0882574055.USD","LU0098860793.USD","LU1929549753.HKD","LU0795875086.SGD","LU0203347892.USD","LU2237443549.SGD","SG9999015978.USD","LU1244550577.SGD","LU1551013425.SGD","LU0310800379.SGD","LU0128525929.USD","LU0965509283.SGD","LU2468319806.SGD","LU0553294199.USD","SG9999001440.SGD","LU0689472784.USD","LU0456855351.SGD","LU0861579265.USD","LU2237443622.USD","LU0289739699.SGD","IE00B2B36J28.USD","LU0511384066.AUD","LU1732799900.SGD","LU0234570918.USD","BK4588","LU0708994859.HKD","LU0820561909.HKD","LU0965509101.SGD","IE00BFTCPJ56.SGD","LU2089284900.SGD","LU0289961442.SGD","LU0256863902.USD","IE00BSNM7G36.USD","LU0058720904.USD","IE00BDGV0183.EUR","LU1718418525.SGD","LU2133065610.SGD","LU0211327993.USD","IE00B19Z3B42.SGD","IE00BVYPNV92.GBP","LU1244550221.USD","LU1061106388.HKD","LU0985320562.USD","LU0203345920.USD","IE00BGHQF631.EUR","IE00BLSP4239.USD","LU1551013342.USD"],"gpt_icon":0},{"id":"1192910344","title":"艾伯维承诺在美投资千亿美元 以换取关税豁免","url":"https://stock-news.laohu8.com/highlight/detail?id=1192910344","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1192910344?lang=zh_cn&edition=full","pubTime":"2026-01-13 11:49","pubTimestamp":1768276177,"startTime":"0","endTime":"0","summary":"艾伯维近日与美国政府签署协议，承诺下调部分药品价格并在美本土投资1000亿美元，以换取特定关税豁免资格。艾伯维在周一发布的声明中表示，本次签署的协议全面响应了上述四项要求。根据协议，未来十年内，艾伯维将把这1000亿美元投向美国本土的研发领域及资本开支项目，其中涵盖药品生产制造环节。作为交换条件，艾伯维将获得关税豁免资格，同时免于受到未来药品定价强制政策的约束。","market":"us","thumbnail":"https://static.tigerbbs.com/819399b2009bd809953aeb10f7e13fae","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/819399b2009bd809953aeb10f7e13fae"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/content/detail/1392071.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["ABBV"],"gpt_icon":0},{"id":"2603579765","title":"艾伯维(ABBV.US)承诺在美投资千亿美元 以换取关税豁免","url":"https://stock-news.laohu8.com/highlight/detail?id=2603579765","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603579765?lang=zh_cn&edition=full","pubTime":"2026-01-13 11:26","pubTimestamp":1768274813,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，艾伯维近日与美国政府签署协议，承诺下调部分药品价格并在美本土投资1000亿美元，以换取特定关税豁免资格。艾伯维在周一发布的声明中表示，本次签署的协议全面响应了上述四项要求。根据协议，未来十年内，艾伯维将把这1000亿美元投向美国本土的研发领域及资本开支项目，其中涵盖药品生产制造环节。作为交换条件，艾伯维将获得关税豁免资格，同时免于受到未来药品定价强制政策的约束。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1392071.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BLSP4239.USD","LU1934455863.HKD","LU1003077747.HKD","LU1718418525.SGD","LU1496350171.SGD","LU2468319806.SGD","LU0098860793.USD","LU0661504455.SGD","LU1037948541.HKD","LU1732799900.SGD","LU1162221912.USD","SG9999015978.USD","LU0965509010.AUD","LU0965509283.SGD","LU2129689431.USD","LU2237443622.USD","LU2237443978.SGD","LU0211327993.USD","LU0965509101.SGD","IE00BBT3K403.USD","LU1244550577.SGD","LU2347655156.SGD","LU0689472784.USD","LU1057294990.SGD","LU0310799852.SGD","LU1267930573.SGD","SG9999015945.SGD","IE00BSNM7G36.USD","LU1023059063.AUD","LU2089984988.USD","LU0912757837.SGD","LU2089284900.SGD","IE00BVYPNV92.GBP","LU1074936037.SGD","LU0256863811.USD","IE00BFTCPJ56.SGD","BK4533","LU0211328371.USD","LU1037948897.HKD","LU1093756168.USD","IE00BN8TJ469.HKD","LU0456855351.SGD","LU2112291526.USD","LU0198837287.USD","LU2237443549.SGD","LU1732800096.USD","LU0158827948.USD","ABBV","IE00B42XCP33.USD","LU1551013342.USD"],"gpt_icon":0},{"id":"1107664320","title":"艾伯维公司未来十年将斥资1000亿美元投入美国研发及资本开支，涵盖制造业","url":"https://stock-news.laohu8.com/highlight/detail?id=1107664320","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1107664320?lang=zh_cn&edition=full","pubTime":"2026-01-13 07:32","pubTimestamp":1768260770,"startTime":"0","endTime":"0","summary":"艾伯维公司宣布，将在未来十年内于美国市场投入高达1000亿美元的资金，重点投向研发活动以及资本性支出，其中制造业相关投资亦被纳入这一庞大计划。这一战略部署彰显了公司对强化本土创新能力和生产基础设施的长期承诺。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3581.USD","LU1291159041.SGD","LU2023251221.USD","SG9999015978.USD","LU1718418525.SGD","LU0882574055.USD","LU1037948541.HKD","LU0310800379.SGD","LU0058720904.USD","LU1732799900.SGD","LU0795875086.SGD","LU1929549753.HKD","LU1023059063.AUD","IE0002270589.USD","IE0004445239.USD","LU0029864427.USD","IE00BJJMRZ35.SGD","LU1934455194.USD","LU1003077747.HKD","IE00B19Z3B42.SGD","LU0795875169.SGD","LU1430594728.SGD","IE00B42XCP33.USD","SG9999015986.USD","LU1585245621.USD","LU2237443622.USD","IE00BVYPNV92.GBP","LU0098860793.USD","LU0122379950.USD","LU1496350502.SGD","LU2089984988.USD","LU0985320562.USD","SG9999001440.SGD","LU0965509010.AUD","LU2237443465.HKD","LU1267930573.SGD","LU0432979614.USD","LU1989772840.SGD","LU2347655156.SGD","LU0256863902.USD","LU0234572021.USD","LU0114720955.EUR","LU0545039389.USD","BK4588","BK4559","IE00BJT1NW94.SGD","LU1037948897.HKD","BK4533","LU0943347566.SGD","LU0310799852.SGD","LU0211327993.USD","LU0456855351.SGD","LU1989771016.USD","LU2237443978.SGD","SG9999015945.SGD","LU2133065610.SGD","LU1839511570.USD","LU0211328371.USD","LU0417517546.SGD","LU1934455277.USD","IE0002141913.USD","LU0661504455.SGD","SG9999011175.SGD","IE00B3PB1722.GBP","LU0320765646.SGD","LU1934455863.HKD","LU2129689605.HKD","LU2112291526.USD","SG9999003800.SGD","LU2089283258.USD","LU0820561909.HKD","LU2237443549.SGD","LU2087621335.USD","LU0949170772.SGD","LU0128525929.USD","LU1989772923.USD","LU0124676726.USD","IE00BDGV0183.EUR","LU0158827948.USD","LU1267930490.SGD","LU0708994859.HKD","IE00BLSP4452.SGD","LU0689472784.USD","LU2468319806.SGD","LU1551013342.USD","IE00BFTCPJ56.SGD","LU0738911758.USD","LU0820561818.USD","LU0203345920.USD","LU1732800096.USD","LU0198837287.USD","LU1244550494.USD","LU0553294199.USD","ABBV","IE00BGHQF631.EUR","LU1496350171.SGD","LU2237443382.USD","LU0170899867.USD","BK4139","IE00BVYPNW00.USD","LU1244550221.USD","LU0289739699.SGD","LU1074936037.SGD","SG9999015952.SGD","BK4550","LU0912757837.SGD","LU1093756168.USD","BK4566","LU1061106388.HKD","LU0965509101.SGD","LU0203347892.USD","LU1057294990.SGD","IE0009355771.USD","BK4581","LU0256863811.USD","IE00B2B36J28.USD","IE00BN8TJ469.HKD","LU2129689514.USD","LU0861579265.USD","LU1162221912.USD","LU2089284900.SGD","LU2237443895.HKD","BK4585","LU0965508806.USD","BK4534","LU1983299246.USD","IE00BSNM7G36.USD","LU1551013425.SGD","LU2129689431.USD","LU1244550577.SGD","LU0689626769.HKD","IE00B4R5TH58.HKD","IE00BBT3K403.USD","IE00BLSP4239.USD","LU1093756325.SGD","LU0965509283.SGD","LU0234570918.USD"],"gpt_icon":0},{"id":"1156023584","title":"艾伯维公司：将通过Trumprx平台为医疗补助计划提供低价药品，并扩大面向患者的可负担直接治疗方案","url":"https://stock-news.laohu8.com/highlight/detail?id=1156023584","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156023584?lang=zh_cn&edition=full","pubTime":"2026-01-13 07:32","pubTimestamp":1768260766,"startTime":"0","endTime":"0","summary":"艾伯维公司宣布，将通过其Trumprx平台为医疗补助计划参与者提供低价药品，同时扩大面向患者的可负担直接治疗方案。这一举措旨在提升药品可及性，让更多患者能够以合理价格获得所需治疗。\n通过Trumprx平台，艾伯维将优化药品供应流程，实现从药企到患者的直接服务模式。该战略不仅涵盖价格优惠，还将简化购药流程，为医疗补助计划受益者及自费患者提供更便捷的用药体验。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BVYPNV92.GBP","LU1267930490.SGD","LU1003077747.HKD","IE00B19Z3581.USD","LU1267930573.SGD","IE00B3PB1722.GBP","LU0098860793.USD","IE00B42XCP33.USD","LU2089984988.USD","LU1732800096.USD","LU2129689431.USD","LU1074936037.SGD","IE00BJJMRZ35.SGD","LU1244550494.USD","BK4534","LU1983299246.USD","IE00BN8TJ469.HKD","LU1244550577.SGD","IE00B4R5TH58.HKD","LU0256863811.USD","LU1934455194.USD","LU0320765646.SGD","LU1244550221.USD","LU0029864427.USD","LU2237443622.USD","LU0965509010.AUD","LU1496350502.SGD","LU2129689605.HKD","IE0002270589.USD","LU0949170772.SGD","SG9999011175.SGD","BK4585","IE00BSNM7G36.USD","SG9999015986.USD","BK4139","LU1732799900.SGD","LU2347655156.SGD","LU0256863902.USD","LU1989771016.USD","LU0310800379.SGD","LU2237443978.SGD","LU1934455277.USD","LU1989772840.SGD","LU1934455863.HKD","LU1023059063.AUD","LU0795875169.SGD","LU0553294199.USD","LU0122379950.USD","LU0158827948.USD","LU1291159041.SGD","IE00BFTCPJ56.SGD","LU0198837287.USD","LU0432979614.USD","LU0708994859.HKD","LU0058720904.USD","IE00BDGV0183.EUR","LU1718418525.SGD","BK4588","LU0965509283.SGD","LU0234572021.USD","IE00B19Z3B42.SGD","LU1093756168.USD","SG9999003800.SGD","LU1929549753.HKD","LU1551013425.SGD","LU0661504455.SGD","LU0738911758.USD","BK4550","LU0861579265.USD","LU0545039389.USD","LU1061106388.HKD","LU0170899867.USD","LU2112291526.USD","LU1093756325.SGD","LU1585245621.USD","LU0128525929.USD","IE00BGHQF631.EUR","LU2129689514.USD","IE0002141913.USD","IE0004445239.USD","SG9999015952.SGD","LU2237443382.USD","LU0211327993.USD","BK4559","LU2089283258.USD","IE00BBT3K403.USD","LU0234570918.USD","IE00B2B36J28.USD","LU2237443549.SGD","IE0009355771.USD","ABBV","LU0820561818.USD","LU0124676726.USD","LU1496350171.SGD","LU2087621335.USD","LU0795875086.SGD","LU0289739699.SGD","IE00BLSP4452.SGD","LU0417517546.SGD","BK4581","LU2237443465.HKD","LU2023251221.USD","LU1989772923.USD","BK4533","SG9999015945.SGD","LU0203347892.USD","LU1057294990.SGD","LU2237443895.HKD","IE00BJT1NW94.SGD","LU0820561909.HKD","LU1430594728.SGD","BK4566","IE00BVYPNW00.USD","LU0310799852.SGD","LU0985320562.USD","LU1037948897.HKD","SG9999015978.USD","LU0203345920.USD","LU2133065610.SGD","LU0882574055.USD","LU1839511570.USD","LU0211328371.USD","LU2089284900.SGD","LU0912757837.SGD","LU0965509101.SGD","LU0456855351.SGD","LU2468319806.SGD","LU0689626769.HKD","LU0114720955.EUR","LU0943347566.SGD","LU1551013342.USD","LU1037948541.HKD","LU1162221912.USD","IE00BLSP4239.USD","LU0689472784.USD","LU0965508806.USD","SG9999001440.SGD"],"gpt_icon":0},{"id":"1107559382","title":"艾伯维与荣昌生物达成协议 后者有望获得高达49.5亿美元里程碑款项","url":"https://stock-news.laohu8.com/highlight/detail?id=1107559382","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1107559382?lang=zh_cn&edition=full","pubTime":"2026-01-12 20:33","pubTimestamp":1768221217,"startTime":"0","endTime":"0","summary":"根据最新合作协议，荣昌生物（Remegen）有资格从艾伯维（AbbVie）获得累计最高达49.5亿美元的款项。这笔巨额资金将涵盖药物研发、监管审批及商业化等多个阶段的里程碑奖励。\n该合作凸显了国际制药巨头对中国生物科技企业创新能力的认可。分段式的付款机制既保障了研发进程的可控性，也为双方创造了共赢的商业前景。随着合作项目的推进，荣昌生物有望通过达成特定技术指标和销售目标激活相应阶段的付款。\n此次交易金额创下中国生物科技企业对外授权合作的新纪录，预示着国内创新药企在全球医药产业链中的地位正在快速提升。双方未透露具体适应症细节，但市场预期该合作可能涉及肿瘤或自身免疫疾病领域的前沿疗法。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3581.USD","LU1291159041.SGD","LU2023251221.USD","SG9999015978.USD","LU1718418525.SGD","LU0882574055.USD","LU1037948541.HKD","LU0310800379.SGD","LU0058720904.USD","LU1064130708.USD","LU1732799900.SGD","LU0795875086.SGD","LU1929549753.HKD","LU1023059063.AUD","IE0002270589.USD","LU2488822045.USD","IE0004445239.USD","LU0029864427.USD","IE00BJJMRZ35.SGD","LU1934455194.USD","LU1003077747.HKD","IE00B19Z3B42.SGD","LU0795875169.SGD","LU1430594728.SGD","IE00B42XCP33.USD","SG9999015986.USD","LU1585245621.USD","LU2237443622.USD","IE00BVYPNV92.GBP","LU0098860793.USD","LU0122379950.USD","LU1496350502.SGD","LU2089984988.USD","LU0985320562.USD","SG9999001440.SGD","LU0965509010.AUD","LU2237443465.HKD","LU1267930573.SGD","LU0432979614.USD","BK0239","LU1989772840.SGD","LU2347655156.SGD","LU0256863902.USD","LU0234572021.USD","688331","LU0114720955.EUR","LU0545039389.USD","BK4588","BK4559","IE00BJT1NW94.SGD","LU1037948897.HKD","BK4533","LU0943347566.SGD","LU0310799852.SGD","LU0211327993.USD","LU0456855351.SGD","LU1989771016.USD","LU2237443978.SGD","SG9999015945.SGD","LU2133065610.SGD","LU1839511570.USD","LU0211328371.USD","LU0417517546.SGD","LU1934455277.USD","IE0002141913.USD","LU0661504455.SGD","SG9999011175.SGD","IE00B3PB1722.GBP","LU0320765646.SGD","LU1934455863.HKD","LU2129689605.HKD","LU2112291526.USD","SG9999003800.SGD","LU2089283258.USD","LU0820561909.HKD","LU2237443549.SGD","LU2087621335.USD","LU0949170772.SGD","LU0128525929.USD","LU1989772923.USD","LU0124676726.USD","IE00BDGV0183.EUR","LU0158827948.USD","LU1064131003.USD","LU1267930490.SGD","LU0708994859.HKD","IE00BLSP4452.SGD","LU0689472784.USD","LU2468319806.SGD","LU1551013342.USD","IE00BFTCPJ56.SGD","LU0738911758.USD","LU0820561818.USD","LU0203345920.USD","LU1732800096.USD","LU0198837287.USD","LU1244550494.USD","LU0553294199.USD","ABBV","IE00BGHQF631.EUR","LU1496350171.SGD","LU2237443382.USD","LU0170899867.USD","BK4139","IE00BVYPNW00.USD","LU1244550221.USD","LU0289739699.SGD","LU1074936037.SGD","LU2148510915.USD","SG9999015952.SGD","BK4550","LU0912757837.SGD","LU1093756168.USD","BK4566","LU1061106388.HKD","LU0965509101.SGD","LU0203347892.USD","LU1057294990.SGD","IE0009355771.USD","BK4581","LU0256863811.USD","IE00B2B36J28.USD","IE00BN8TJ469.HKD","LU2129689514.USD","LU0861579265.USD","LU1162221912.USD","LU2089284900.SGD","LU2237443895.HKD","BK4585","LU0965508806.USD","BK4534","LU1983299246.USD","IE00BSNM7G36.USD","LU1551013425.SGD","LU2129689431.USD","LU1244550577.SGD","LU0689626769.HKD","IE00B4R5TH58.HKD","IE00BBT3K403.USD","IE00BLSP4239.USD","LU1093756325.SGD","LU0965509283.SGD","LU0234570918.USD"],"gpt_icon":0},{"id":"1140361953","title":"艾伯维收购亚利桑那州生产设施，持续强化美国本土制造能力","url":"https://stock-news.laohu8.com/highlight/detail?id=1140361953","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140361953?lang=zh_cn&edition=full","pubTime":"2026-01-12 19:01","pubTimestamp":1768215713,"startTime":"0","endTime":"0","summary":"艾伯维公司近日宣布，将收购位于亚利桑那州的一处生产设施。这一战略举措旨在进一步增强其在美国本土的制造实力，为未来的产品供应提供有力保障。收购完成后，该设施将整合进艾伯维现有的生产网络，提升其在关键治疗领域的产能与灵活性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1929549753.HKD","LU0128525929.USD","IE00B3PB1722.GBP","LU2089984988.USD","BK4559","LU1983299246.USD","LU1267930490.SGD","LU0106261612.USD","LU2237443895.HKD","BK4533","LU1244550494.USD","LU1267930573.SGD","LU2347655156.SGD","LU2468319806.SGD","IE00B42XCP33.USD","IE00BVYPNW00.USD","LU2133065610.SGD","LU2129689605.HKD","SG9999015986.USD","BK4139","LU1989772840.SGD","IE00B64QTZ34.USD","BK4550","LU1934455277.USD","IE00BLSP4452.SGD","LU1551013342.USD","SG9999015952.SGD","LU1162221912.USD","LU0965509283.SGD","LU0234572021.USD","SG9999015978.USD","LU0820561818.USD","LU1244550577.SGD","LU0234570918.USD","LU1244550221.USD","LU0985320562.USD","IE00BGHQF631.EUR","BK4566","LU1074936037.SGD","LU1718418525.SGD","IE00BDGV0183.EUR","LU0553294199.USD","IE00B19Z3581.USD","LU1093756168.USD","LU0965509101.SGD","LU1839511570.USD","ABBV","IE00BJJMRZ35.SGD","LU0122379950.USD","LU2112291526.USD","IE0009355771.USD","LU0170899867.USD","LU1934455863.HKD","LU0861579265.USD","LU1989771016.USD","LU0256863811.USD","BK4121","LU0098860793.USD","LU0912757837.SGD","IE00B19Z3B42.SGD","LU0949170772.SGD","LU1585245621.USD","LU0456855351.SGD","LU0058720904.USD","LU0320765646.SGD","LU1061106388.HKD","LU1093756325.SGD","LU0114720955.EUR","IE00BYQQ9H92.USD","LU1037948541.HKD","LU1003077747.HKD","LU0661504455.SGD","LU2089283258.USD","LU0432979614.USD","LU0211327993.USD","LU0943347566.SGD","LU0289739699.SGD","LU2129689514.USD","LU1057294990.SGD","LU0310799852.SGD","LU2089284900.SGD","IE00BSNM7G36.USD","IE0002270589.USD","SG9999015945.SGD","LU2237443622.USD","LU0345774631.USD","BK4534","BK4567","LU0158827948.USD","IE00BJT1NW94.SGD","IE00BVYPNV92.GBP","LU0345774391.USD","SG9999003800.SGD","LU1732800096.USD","LU1989772923.USD","LU0203347892.USD","LU2087621335.USD","LU2237443382.USD","LU2237443549.SGD","LU0965509010.AUD","LU1037948897.HKD","BK4588","LU1551013425.SGD","BK4581","LU0689626769.HKD","LU2237443978.SGD","IE00BBT3K403.USD","SG9999011175.SGD","LU2237443465.HKD","LU1291159041.SGD","BK4585","LU1430594728.SGD","IE00B2B36J28.USD","WST","LU0012050646.USD","IE00BFTCPJ56.SGD","IE00BFXG0V08.USD","LU1496350502.SGD","IE0002141913.USD","IE00BN8TJ469.HKD","LU0256863902.USD","LU0310800379.SGD","LU0965508806.USD","LU0203345920.USD","LU0198837287.USD","LU1496350171.SGD","LU2023251221.USD","BK4504","LU0795875169.SGD","LU0708994859.HKD","LU1934455194.USD","LU0882574055.USD","LU0417517546.SGD","SG9999001440.SGD","LU2129689431.USD","IE0004445239.USD","IE00BLSP4239.USD","LU1023059063.AUD","LU0211328371.USD","LU0689472784.USD","IE00B4R5TH58.HKD","LU0820561909.HKD","LU0545039389.USD","LU1732799900.SGD","LU0795875086.SGD","LU0029864427.USD","LU0738911758.USD","LU0124676726.USD"],"gpt_icon":0},{"id":"2602037039","title":"默沙东关注RVMD 艾伯维否认兴趣","url":"https://stock-news.laohu8.com/highlight/detail?id=2602037039","media":"环球市场播报","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602037039?lang=zh_cn&edition=full","pubTime":"2026-01-10 00:09","pubTimestamp":1767974940,"startTime":"0","endTime":"0","summary":"默沙东（MRK）周五早盘下跌0.3%。据英国《金融时报》报道，正洽谈以潜在数十亿美元交易收购Revolution Medicines（RVMD），此前一天艾伯维（ABBV）表示未与该生物技术公司进行讨论。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：张俊 SF065","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c2d46f3176d31be87e42705d65675998","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-01-10/doc-inhftucf5577600.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1929549753.HKD","LU2106854487.HKD","LU2089984988.USD","BK4559","LU0211331839.USD","LU1983299246.USD","BK4533","LU2468319806.SGD","LU1116320737.USD","LU1066051225.USD","LU2023250843.SGD","BK4139","LU1989772840.SGD","LU2361045086.USD","SG9999014542.SGD","BK4550","IE00B1BXHZ80.USD","LU1934455277.USD","IE00BLSP4452.SGD","LU2324357040.USD","MRK","LU1162221912.USD","LU0965509283.SGD","LU0234572021.USD","SG9999001176.SGD","LU0006306889.USD","LU2125154778.USD","LU0985320562.USD","LU0648001328.SGD","LU2461242641.AUD","LU0106261372.USD","LU1941712264.USD","LU1093756168.USD","LU0965509101.SGD","LU1066053197.SGD","LU1201861249.SGD","LU2361044865.SGD","SG9999015358.SGD","LU0130517989.USD","ABBV","IE00BJJMRZ35.SGD","LU0122379950.USD","LU2112291526.USD","IE0009355771.USD","LU0208291251.USD","LU1934455863.HKD","LU1917777945.USD","LU0861579265.USD","LU1989771016.USD","LU0098860793.USD","LU1585245621.USD","LU1699723380.USD","LU0058720904.USD","LU2023250504.SGD","LU0320765646.SGD","LU0980610538.SGD","LU1061106388.HKD","LU1093756325.SGD","SG9999015341.SGD","SG9999014559.SGD","LU1037948541.HKD","LU2361044949.HKD","LU0266013472.USD","LU1974910355.USD","SG9999013999.USD","LU0238689110.USD","LU0289739699.SGD","LU1057294990.SGD","IE00BSNM7G36.USD","LU0130102774.USD","BK4534","IE00BJT1NW94.SGD","LU1069347547.HKD","SG9999014567.USD","LU1989772923.USD","LU0203347892.USD","BK4516","LU0965509010.AUD","LU0070302665.USD","LU1037948897.HKD","BK4588","LU0265550359.USD","IE00BBT3K403.USD","SG9999002224.SGD","LU1571399168.USD","LU0477156953.USD","LU1291159041.SGD","BK4585","BK4007","LU1035773651.USD","IE00B2B36J28.USD","LU1430594728.SGD","LU2125154935.USD","IE00BFTCPJ56.SGD","SG9999001176.USD","LU0320765489.SGD","IE0002141913.USD","IE00BN8TJ469.HKD","RVMD","LU0965508806.USD","LU0203345920.USD","IE000M9KFDE8.USD","LU1116320901.HKD","LU1066051498.USD","LU1934455194.USD","SG9999001440.SGD","LU1941712348.USD","LU2360032135.SGD","SG9999014575.USD","IE00BLSP4239.USD","LU1023059063.AUD","LU1066051811.HKD","LU0265550946.USD","IE00B4R5TH58.HKD","SG9999002232.USD","SGXZ57979304.SGD"],"gpt_icon":0},{"id":"1142509752","title":"艾伯维否认与Revolution Medicines洽谈，后者股价盘后重挫13.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1142509752","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142509752?lang=zh_cn&edition=full","pubTime":"2026-01-08 05:22","pubTimestamp":1767820976,"startTime":"0","endTime":"0","summary":"在艾伯维公开澄清未与Revolution Medicines进行任何谈判后，Revolution Medicines股价于盘后交易时段急速下挫，跌幅高达13.5%。这一声明直接冲击了市场对双方潜在合作的预期，导致投资者迅速抛售股票。股价的剧烈波动反映出市场对生物制药公司间合作消息的高度敏感，任何传闻的澄清或否认都可能引发显著价格调整。此次下跌凸显了投资者在缺乏实质性合作进展时的谨慎态度，以及对相关消息的即时反应。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3581.USD","LU1162221912.USD","LU1929549753.HKD","LU0882574055.USD","LU0203345920.USD","LU0211328371.USD","LU0965509101.SGD","LU1718418525.SGD","LU0029864427.USD","LU2237443978.SGD","LU2089984988.USD","LU0985320562.USD","SG9999015952.SGD","LU1003077747.HKD","LU1057294990.SGD","LU1037948541.HKD","LU1732799900.SGD","BK4534","IE00B2B36J28.USD","LU0122379950.USD","BK4533","LU0432979614.USD","LU1267930490.SGD","LU0310799852.SGD","IE00B3PB1722.GBP","IE00BBT3K403.USD","LU2468319806.SGD","ABBV","LU0965508806.USD","LU0234570918.USD","LU1023059063.AUD","LU1989772923.USD","LU2112291526.USD","LU2237443622.USD","LU0310800379.SGD","LU1934455863.HKD","LU1983299246.USD","SG9999015945.SGD","LU1430594728.SGD","LU0128525929.USD","IE00BGHQF631.EUR","LU2089284900.SGD","SG9999003800.SGD","IE00BLSP4239.USD","LU0708994859.HKD","LU0289739699.SGD","LU0795875169.SGD","LU0553294199.USD","IE00BSNM7G36.USD","IE00BVYPNW00.USD","LU2133065610.SGD","LU1839511570.USD","LU0417517546.SGD","LU0795875086.SGD","IE00BVYPNV92.GBP","LU0965509283.SGD","LU1989771016.USD","LU0170899867.USD","LU0545039389.USD","LU1989772840.SGD","LU1934455277.USD","LU0203347892.USD","IE0002270589.USD","LU1551013425.SGD","LU0820561818.USD","LU1244550221.USD","LU0114720955.EUR","LU2087621335.USD","LU0949170772.SGD","LU2347655156.SGD","LU1061106388.HKD","LU1551013342.USD","LU0124676726.USD","IE00BLSP4452.SGD","LU0158827948.USD","LU0738911758.USD","IE00B42XCP33.USD","LU2089283258.USD","LU0198837287.USD","LU0861579265.USD","LU1093756168.USD","LU1585245621.USD","LU0256863902.USD","LU0058720904.USD","LU1267930573.SGD","SG9999011175.SGD","LU0211327993.USD","LU1244550494.USD","LU1732800096.USD","LU2237443549.SGD","SG9999015986.USD","LU0943347566.SGD","LU0256863811.USD","LU1093756325.SGD","LU0098860793.USD","BK4566","LU0965509010.AUD","IE0002141913.USD","LU2129689514.USD","BK4588","LU1496350502.SGD","IE00BN8TJ469.HKD","BK4139","BK4559","IE0009355771.USD","LU2237443465.HKD","LU1934455194.USD","LU2237443895.HKD","LU2023251221.USD","LU2129689431.USD","BK4585","IE00BFTCPJ56.SGD","BK4581","SG9999015978.USD","LU0912757837.SGD","IE0004445239.USD","LU0320765646.SGD","LU0689472784.USD","LU0689626769.HKD","LU0820561909.HKD","IE00BDGV0183.EUR","LU2129689605.HKD","LU0234572021.USD","LU1496350171.SGD","LU0661504455.SGD","SG9999001440.SGD","LU1244550577.SGD","IE00B4R5TH58.HKD","LU0456855351.SGD","BK4550","LU1074936037.SGD","LU1037948897.HKD","IE00B19Z3B42.SGD","LU1291159041.SGD","LU2237443382.USD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD"],"gpt_icon":0},{"id":"2600118059","title":"艾伯维12亿美元押注三抗TCE，与泽璟达成合作和授权协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2600118059","media":"Minhua笔记","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600118059?lang=zh_cn&edition=full","pubTime":"2026-01-01 15:22","pubTimestamp":1767252148,"startTime":"0","endTime":"0","summary":"艾伯维正通过一项可能高达12亿美元的交易，进一步拓展其在肿瘤免疫治疗领域的布局。该交易包括向泽璟支付1亿美元的首付款，以及高达6000万美元的近期临床和选择权相关款项。艾伯维在2025年通过两项以三特异性抗体为核心的交易，进一步丰富了其肿瘤产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260101154040a6e831da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260101154040a6e831da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1244550494.USD","LU1732800096.USD","LU0820561909.HKD","SG9999003800.SGD","LU1934455194.USD","LU0256863902.USD","SG9999015986.USD","ABBV","SG9999015945.SGD","LU0310799852.SGD","LU0211327993.USD","LU0795875086.SGD","LU1093756168.USD","SG9999011175.SGD","LU0432979614.USD","LU1267930490.SGD","BK4559","LU2129689431.USD","IE00B2B36J28.USD","IE00B42XCP33.USD","LU2089984988.USD","IE00B19Z3581.USD","LU2089284900.SGD","LU2112291526.USD","LU1057294990.SGD","LU0965509283.SGD","LU1718418525.SGD","LU1732799900.SGD","LU2237443895.HKD","LU1989772923.USD","LU0661504455.SGD","LU0158827948.USD","LU0965509010.AUD","LU2347655156.SGD","LU1934455277.USD","LU0320765646.SGD","IE0002270589.USD","LU0738911758.USD","LU1496350502.SGD","BK4550","LU1585245621.USD","LU0058720904.USD","IE00BLSP4239.USD","IE0004445239.USD","IE00B4R5TH58.HKD","LU1989772840.SGD","LU0965509101.SGD","LU2237443549.SGD","BK4139","IE00B19Z3B42.SGD"],"gpt_icon":0},{"id":"1165741365","title":"泽璟制药与艾伯维达成许可协议 有望获1亿美元首付款及11亿美元里程碑付款","url":"https://stock-news.laohu8.com/highlight/detail?id=1165741365","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1165741365?lang=zh_cn&edition=full","pubTime":"2025-12-31 17:31","pubTimestamp":1767173475,"startTime":"0","endTime":"0","summary":"泽璟制药宣布，若合作方艾伯维公司行使许可选择权，公司将获得1亿美元的首付款，并有资格获得最高达11亿美元的里程碑付款。此次合作涉及特定创新药物的授权许可，彰显了泽璟制药研发实力的国际认可。协议具体条款将根据研发进展分阶段触发付款条件，为泽璟制药带来长期现金流支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0820561909.HKD","LU1934455194.USD","LU1244550577.SGD","IE00BN8TJ469.HKD","IE00BVYPNV92.GBP","LU0122379950.USD","ABBV","IE00BBT3K403.USD","LU1934455863.HKD","LU1989771016.USD","LU0211328371.USD","LU0310800379.SGD","LU1934455277.USD","LU2089984988.USD","SG9999015945.SGD","LU2237443549.SGD","IE00BVYPNW00.USD","IE00B4R5TH58.HKD","LU0289739699.SGD","IE0009355771.USD","LU2112291526.USD","IE00BJJMRZ35.SGD","LU0553294199.USD","IE0002141913.USD","BK4566","IE00BJT1NW94.SGD","LU0114720955.EUR","BK4550","IE00BSNM7G36.USD","LU0456855351.SGD","BK4139","IE00BGHQF631.EUR","LU1093756325.SGD","LU1162221912.USD","LU0912757837.SGD","LU0689472784.USD","LU0689626769.HKD","LU2237443622.USD","LU1244550494.USD","LU2237443382.USD","LU0124676726.USD","LU2129689514.USD","LU1732800096.USD","LU0211327993.USD","LU1585245621.USD","LU2237443978.SGD","LU2237443465.HKD","LU0965508806.USD","688266","LU0795875169.SGD","LU1430594728.SGD","LU0708994859.HKD","IE00B42XCP33.USD","LU1267930573.SGD","LU2347655156.SGD","IE00BLSP4239.USD","LU0058720904.USD","LU0234570918.USD","LU2133065610.SGD","LU0661504455.SGD","LU0861579265.USD","LU0098860793.USD","LU1291159041.SGD","IE00BDGV0183.EUR","LU2468319806.SGD","LU1989772923.USD","LU0943347566.SGD","LU0203345920.USD","SG9999015986.USD","IE00B19Z3581.USD","LU0310799852.SGD","LU0128525929.USD","LU0795875086.SGD","SG9999003800.SGD","LU0320765646.SGD","BK4581","LU1003077747.HKD","LU2023251221.USD","LU0965509101.SGD","IE0002270589.USD","BK4588","LU1057294990.SGD","LU1244550221.USD","LU1929549753.HKD","LU0256863902.USD","LU0949170772.SGD","LU0882574055.USD","BK4585","LU1023059063.AUD","LU2087621335.USD","LU2129689605.HKD","IE00BFTCPJ56.SGD","SG9999001440.SGD","LU1983299246.USD","LU1989772840.SGD","LU0256863811.USD","LU1732799900.SGD","LU0158827948.USD","LU1551013425.SGD","BK4533","LU2129689431.USD","SG9999011175.SGD","IE00BLSP4452.SGD","LU1061106388.HKD","IE00B3PB1722.GBP","LU1074936037.SGD","LU0738911758.USD","LU2089283258.USD","LU1496350502.SGD","LU0029864427.USD","LU1839511570.USD","LU0170899867.USD","LU1037948897.HKD","BK4534","SG9999015952.SGD","IE00B19Z3B42.SGD","LU0965509010.AUD","LU1718418525.SGD","LU2237443895.HKD","LU1037948541.HKD","SG9999015978.USD","LU0234572021.USD","LU1496350171.SGD","LU0965509283.SGD","LU1093756168.USD","LU0985320562.USD","IE0004445239.USD","LU1267930490.SGD","LU0820561818.USD","LU0417517546.SGD","LU0203347892.USD","LU0198837287.USD","LU0545039389.USD","LU1551013342.USD","IE00B2B36J28.USD","LU2089284900.SGD","BK4559","LU0432979614.USD","BK0239"],"gpt_icon":0},{"id":"1177773699","title":"泽璟制药与艾伯维就阿尔维塔米格达成战略合作，共同推进研发与商业化","url":"https://stock-news.laohu8.com/highlight/detail?id=1177773699","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1177773699?lang=zh_cn&edition=full","pubTime":"2025-12-31 17:31","pubTimestamp":1767173473,"startTime":"0","endTime":"0","summary":"泽璟制药宣布，已与艾伯维公司签署一项战略合作协议，双方将就阿尔维塔米格的开发及商业化展开深度合作。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B4R5TH58.HKD","LU1989771016.USD","SG9999015978.USD","LU0256863902.USD","LU0708994859.HKD","IE00BJJMRZ35.SGD","LU1093756325.SGD","LU1551013425.SGD","BK4139","BK4559","LU0098860793.USD","LU1037948541.HKD","LU0949170772.SGD","IE00B19Z3581.USD","LU0211327993.USD","LU2129689514.USD","688266","LU0432979614.USD","LU0114720955.EUR","IE00BGHQF631.EUR","IE00BLSP4239.USD","LU0820561909.HKD","IE00B19Z3B42.SGD","LU0029864427.USD","LU1496350502.SGD","LU2237443978.SGD","LU1732799900.SGD","LU0689626769.HKD","LU0320765646.SGD","LU1934455863.HKD","LU2129689431.USD","LU0122379950.USD","LU0456855351.SGD","LU0417517546.SGD","LU1291159041.SGD","LU0128525929.USD","LU0553294199.USD","LU1496350171.SGD","LU0795875086.SGD","SG9999001440.SGD","BK4533","LU1074936037.SGD","LU1162221912.USD","IE00BFTCPJ56.SGD","LU0861579265.USD","LU1551013342.USD","LU2133065610.SGD","IE0004445239.USD","LU1585245621.USD","LU2129689605.HKD","IE00BN8TJ469.HKD","LU0661504455.SGD","LU0203347892.USD","BK4585","IE00B3PB1722.GBP","IE00BSNM7G36.USD","LU1023059063.AUD","IE00BVYPNW00.USD","LU2089984988.USD","IE00BVYPNV92.GBP","LU2237443895.HKD","LU0545039389.USD","LU0310799852.SGD","LU1989772923.USD","LU1983299246.USD","IE00BDGV0183.EUR","LU1244550494.USD","LU0198837287.USD","LU2237443465.HKD","LU0289739699.SGD","LU0234572021.USD","IE00BJT1NW94.SGD","LU0256863811.USD","LU0058720904.USD","IE0002270589.USD","LU1430594728.SGD","BK4534","SG9999011175.SGD","BK4550","LU1057294990.SGD","LU0882574055.USD","SG9999015945.SGD","BK4566","LU2347655156.SGD","LU1037948897.HKD","LU0234570918.USD","LU1061106388.HKD","SG9999015986.USD","IE00B42XCP33.USD","LU0965509283.SGD","LU2468319806.SGD","LU0985320562.USD","LU2237443622.USD","LU0820561818.USD","IE0009355771.USD","SG9999015952.SGD","LU0158827948.USD","BK4581","LU0203345920.USD","LU0124676726.USD","LU1732800096.USD","LU0738911758.USD","LU0689472784.USD","LU1244550577.SGD","LU2237443549.SGD","LU0943347566.SGD","LU0211328371.USD","LU0795875169.SGD","LU0965509101.SGD","LU1093756168.USD","LU2112291526.USD","LU0170899867.USD","LU1989772840.SGD","LU0965508806.USD","LU1839511570.USD","LU1929549753.HKD","LU1718418525.SGD","SG9999003800.SGD","LU1267930490.SGD","IE0002141913.USD","LU1934455277.USD","LU1267930573.SGD","LU2089283258.USD","ABBV","IE00B2B36J28.USD","LU2237443382.USD","LU2023251221.USD","BK0239","LU1003077747.HKD","LU0310800379.SGD","LU2089284900.SGD","BK4588","IE00BLSP4452.SGD","LU0965509010.AUD","IE00BBT3K403.USD","LU2087621335.USD","LU1244550221.USD","LU1934455194.USD","LU0912757837.SGD"],"gpt_icon":0},{"id":"2592139231","title":"默沙东(MRK.US)、施贵宝(BMY.US)等多家药企同意下调美国药价 以换取特朗普政府关税豁免和政策支持","url":"https://stock-news.laohu8.com/highlight/detail?id=2592139231","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592139231?lang=zh_cn&edition=full","pubTime":"2025-12-20 07:00","pubTimestamp":1766185200,"startTime":"0","endTime":"0","summary":"美国总统特朗普推动将美国药价与海外低价市场挂钩之际，多家美国及欧洲大型制药企业近日与白宫达成协议，同意自愿下调在美销售的药品价格，以换取关税豁免和政策支持。在此次协议中，最受市场关注的是施贵宝的让利承诺。特朗普在周五的公开活动上表示，今年7月他致信要求降价的17家大型制药企业中，已有14家同意大幅下调药价。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"2acbaf8fbf691a451fa9ea170ee88816","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384042.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BJT1NW94.SGD","LU1868837136.USD","LU0965508806.USD","LU2112291526.USD","LU1066053197.SGD","LU0320765489.SGD","SG9999014559.SGD","IE00B1BXHZ80.USD","LU0237698245.USD","IE00BSNM7G36.USD","LU1162221912.USD","LU1868836591.USD","LU1718418525.SGD","LU0130517989.USD","LU1585245621.USD","LU1929549753.HKD","JNJ","LU0320765646.SGD","LU1670711123.USD","LU0265550359.USD","AMGN","BK4007","LU0130102774.USD","IE000M9KFDE8.USD","IE00BLSP4239.USD","SG9999014567.USD","LU2361044949.HKD","GILD","BK4534","LU0965509283.SGD","LU0070302665.USD","LU0096364046.USD","LU1430594728.SGD","LU2125154778.USD","LU1868836757.USD","LU1983299246.USD","IE00BFXG1179.USD","LU1989772840.SGD","SG9999001176.USD","LU2324357040.USD","LU1868836914.USD","IE0002141913.USD","LU2023250843.SGD","LU0098860793.USD","LU1699723380.USD","MRK","LU1323610961.USD","REGN","IE00B2B36J28.USD","LU1989771016.USD","SG9999001440.SGD","LU0114720955.EUR","LU1023059063.AUD","LU1069347547.HKD","SGXZ57979304.SGD","IE00BJJMRZ35.SGD","LU1116320901.HKD","BK4588","LU1093756168.USD","LU1974910355.USD","LU1917777945.USD","LU1934455863.HKD","LU0965509010.AUD","LU1670711040.USD","LU0006306889.USD","LU0266013472.USD","LU0648001328.SGD","LU2125154935.USD","LU1061106388.HKD","ROG","LU0289739699.SGD","BK4559","BK4516","LU1868837300.USD","LU1941712264.USD","LU0211331839.USD","LU1066051498.USD","LU2360032135.SGD","LU1291159041.SGD","BK4550","LU1035773651.USD","SG9999002232.USD","LU1074936037.SGD","LU2242646821.SGD","IE00BLSP4452.SGD","LU0965509101.SGD","SG9999002224.SGD","SG9999015358.SGD","SG9999001176.SGD","LU0225284248.USD","LU1670710588.SGD","LU0208291251.USD","LU1201861249.SGD","LU0061475181.USD","IE00B4R5TH58.HKD","LU2106854487.HKD","LU0861579265.USD","04332","LU1032466523.USD","LU1037948541.HKD","LU2023250504.SGD","BK4533","LU1261432733.SGD","NVS","LU1670710661.SGD","LU0058720904.USD","LU0203345920.USD","LU0321505439.SGD","LU2361044865.SGD","LU0882574055.USD","BK4585","LU0985481810.HKD","IE00BN8TJ469.HKD","LU1116320737.USD","LU1934455194.USD","LU0122379950.USD","LU2089984988.USD","LU0868494617.USD","LU0306807586.USD","LU0456855351.SGD","ABBV","BK4532","LU0985320562.USD","LU0306806265.USD","LU1037948897.HKD","LU1571399168.USD","LU2133065610.SGD","LU1057294990.SGD","SG9999014542.SGD","GSK","BK4581","LU0234572021.USD","BMY","LU0225771236.USD","LU1093756325.SGD","LU0238689110.USD","SG9999015341.SGD","LU1934455277.USD","SG9999013999.USD","LU0267386448.USD","IE0009355771.USD","IE00BBT3K403.USD","LU0203347892.USD","LU2242652126.USD","LU1066051225.USD","LU2461242641.AUD","LU0980610538.SGD","LU0106261372.USD","LU1941712348.USD","LU1066051811.HKD","SNY","AZN","LU2468319806.SGD","LU1989772923.USD","LU0321505868.SGD","LU0477156953.USD","LU0265550946.USD","IE00BFTCPJ56.SGD","LU2361045086.USD","SG9999014575.USD"],"gpt_icon":1},{"id":"1194063589","title":"2026年可买入这10只高股息美股股票","url":"https://stock-news.laohu8.com/highlight/detail?id=1194063589","media":"老虎资讯综合","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194063589?lang=zh_cn&edition=full","pubTime":"2025-12-11 21:23","pubTimestamp":1765459419,"startTime":"0","endTime":"0","summary":"从积极面来看，2026年总红利额预计将再创纪录。他预计标普500指数2026年的盈利增长将达到14%，而2025年的预期为9%至10%。2022年，标普500每股股息增长10.8%，这是在疫情期间大量削减及暂停派息后的一次强劲恢复。Wolfe Research跟踪的一篮子高股息股票目前较大盘有约40%的折价。展望2026年，另一个值得关注高股息来源的地方是标普500红利贵族。","market":"us","thumbnail":"https://community-static.tradeup.com/news/407e7928933aadc4f76aebfab1f160b4","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/407e7928933aadc4f76aebfab1f160b4"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QCOM","SJM","NTRS","FDX","PG","KO","ABBV","PBI","XOM"],"gpt_icon":1},{"id":"1115041981","title":"OSE Immunotherapeutics Sa - 艾伯维公司保留未来开发和商业化的控制权","url":"https://stock-news.laohu8.com/highlight/detail?id=1115041981","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115041981?lang=zh_cn&edition=full","pubTime":"2025-12-08 14:33","pubTimestamp":1765175596,"startTime":"0","endTime":"0","summary":"OSE Immunotherapeutics Sa - 艾伯维公司保留未来开发和商业化的控制权","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1934455863.HKD","LU2089984988.USD","LU0708994859.HKD","LU1718418525.SGD","IE00B19Z3B42.SGD","LU1244550494.USD","IE00BGHQF631.EUR","IE00BLSP4239.USD","LU0965508806.USD","IE0002141913.USD","LU0058720904.USD","LU2237443895.HKD","SG9999011175.SGD","IE00BJJMRZ35.SGD","LU0949170772.SGD","LU0795875086.SGD","IE00BJT1NW94.SGD","IE00BVYPNW00.USD","LU1732800096.USD","BK4559","LU2023251221.USD","LU0553294199.USD","LU0289739699.SGD","LU0203347892.USD","LU0661504455.SGD","LU0912757837.SGD","LU0310799852.SGD","BK4588","LU1732799900.SGD","LU0234572021.USD","LU1093756325.SGD","LU1934455194.USD","LU2087621335.USD","LU2237443549.SGD","LU1983299246.USD","LU1023059063.AUD","BK4533","IE00B2B36J28.USD","IE0002270589.USD","BK4585","LU0203345920.USD","LU1244550221.USD","LU0820561818.USD","LU1989772923.USD","LU0310800379.SGD","LU0795875169.SGD","LU1839511570.USD","LU0689472784.USD","LU0256863902.USD","LU0417517546.SGD","LU2468319806.SGD","LU0545039389.USD","SG9999001440.SGD","LU1989771016.USD","BK4566","LU2112291526.USD","IE00BFTCPJ56.SGD","ABBV","LU1037948897.HKD","LU1496350171.SGD","LU0124676726.USD","SG9999003800.SGD","LU0114720955.EUR","LU0170899867.USD","LU0943347566.SGD","LU2237443622.USD","LU0738911758.USD","IE00B3PB1722.GBP","IE00BSNM7G36.USD","BK4581","IE0009355771.USD","IE00BN8TJ469.HKD","LU0965509283.SGD","LU1003077747.HKD","LU0456855351.SGD","LU1244550577.SGD","SG9999015978.USD","LU1934455277.USD","LU2089284900.SGD","LU0234570918.USD","LU1496350502.SGD","LU2237443382.USD","LU0985320562.USD","LU1430594728.SGD","BK4534","LU2133065610.SGD","LU2089283258.USD","LU0861579265.USD","LU1267930573.SGD","SG9999015986.USD","LU1551013342.USD","IE00B4R5TH58.HKD","LU1057294990.SGD","LU2237443465.HKD","IE00BBT3K403.USD","LU1093756168.USD","IE00B19Z3581.USD","SG9999015952.SGD","IE0004445239.USD","LU2347655156.SGD","LU0198837287.USD","LU1061106388.HKD","LU0432979614.USD","LU1989772840.SGD","LU2129689605.HKD","LU0029864427.USD","LU1162221912.USD","SG9999015945.SGD","LU0158827948.USD","LU0256863811.USD","LU0122379950.USD","LU0320765646.SGD","LU1929549753.HKD","LU0965509101.SGD","LU0820561909.HKD","LU1551013425.SGD","IE00BLSP4452.SGD","LU0965509010.AUD","LU0128525929.USD","LU2129689431.USD","LU0689626769.HKD","LU0882574055.USD","LU1074936037.SGD","IE00BDGV0183.EUR","LU2129689514.USD","IE00BVYPNV92.GBP","IE00B42XCP33.USD","LU0211328371.USD","BK4550","LU1037948541.HKD","LU1291159041.SGD","BK4139","LU2237443978.SGD","LU1267930490.SGD","LU0211327993.USD","LU1585245621.USD"],"gpt_icon":0},{"id":"1186598515","title":"OSE Immunotherapeutics Sa - 在修订协议下重新掌控Abbv-230早期开发","url":"https://stock-news.laohu8.com/highlight/detail?id=1186598515","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186598515?lang=zh_cn&edition=full","pubTime":"2025-12-08 14:33","pubTimestamp":1765175593,"startTime":"0","endTime":"0","summary":"OSE Immunotherapeutics Sa - 在修订协议下重新掌控Abbv-230早期开发","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128525929.USD","LU2112291526.USD","IE00BLSP4452.SGD","LU0689472784.USD","LU0432979614.USD","LU1291159041.SGD","LU0124676726.USD","LU0256863811.USD","LU0949170772.SGD","LU1839511570.USD","ABBV","LU2237443549.SGD","IE00BGHQF631.EUR","LU1585245621.USD","IE00BDGV0183.EUR","SG9999015945.SGD","LU0289739699.SGD","LU0198837287.USD","LU0211327993.USD","LU0310800379.SGD","LU1267930573.SGD","IE0004445239.USD","IE00BSNM7G36.USD","LU0234570918.USD","IE00BBT3K403.USD","BK4550","LU0029864427.USD","IE00B19Z3B42.SGD","LU1551013342.USD","IE00BFTCPJ56.SGD","LU0122379950.USD","IE00B42XCP33.USD","LU0820561909.HKD","LU1732799900.SGD","LU0965508806.USD","IE00BN8TJ469.HKD","SG9999011175.SGD","LU1267930490.SGD","LU0545039389.USD","LU2237443978.SGD","LU0170899867.USD","IE00B4R5TH58.HKD","LU0820561818.USD","LU1093756168.USD","LU1023059063.AUD","LU1989772840.SGD","LU1496350502.SGD","IE00BLSP4239.USD","BK4534","LU0795875169.SGD","LU1244550577.SGD","IE0002270589.USD","LU1093756325.SGD","LU2087621335.USD","LU0310799852.SGD","IE0009355771.USD","BK4566","LU0943347566.SGD","BK4139","LU0058720904.USD","LU0256863902.USD","LU2089284900.SGD","BK4533","LU1934455863.HKD","LU0985320562.USD","LU0320765646.SGD","LU0965509101.SGD","LU0417517546.SGD","LU0795875086.SGD","LU1244550221.USD","LU0738911758.USD","LU0861579265.USD","LU2129689514.USD","LU1934455277.USD","LU2129689605.HKD","LU2237443895.HKD","LU0203347892.USD","LU2089984988.USD","SG9999001440.SGD","IE00BJJMRZ35.SGD","SG9999015978.USD","BK4581","SG9999003800.SGD","LU2347655156.SGD","BK4559","IE00B2B36J28.USD","IE00B3PB1722.GBP","LU2089283258.USD","IE00BVYPNV92.GBP","LU1929549753.HKD","LU0708994859.HKD","LU0456855351.SGD","LU0661504455.SGD","LU0689626769.HKD","LU1074936037.SGD","IE0002141913.USD","LU2133065610.SGD","LU1037948541.HKD","LU2237443465.HKD","LU2237443622.USD","BK4588","LU1989771016.USD","LU2237443382.USD","LU1983299246.USD","LU1003077747.HKD","SG9999015952.SGD","LU0158827948.USD","LU1718418525.SGD","LU1244550494.USD","LU1496350171.SGD","LU1430594728.SGD","LU0965509010.AUD","IE00BVYPNW00.USD","LU1732800096.USD","LU0203345920.USD","LU1057294990.SGD","LU2129689431.USD","LU2023251221.USD","LU0211328371.USD","LU0553294199.USD","LU1061106388.HKD","LU0965509283.SGD","IE00B19Z3581.USD","LU1162221912.USD","BK4585","LU1989772923.USD","LU1934455194.USD","LU1037948897.HKD","LU1551013425.SGD","LU2468319806.SGD","LU0912757837.SGD","LU0234572021.USD","LU0114720955.EUR","LU0882574055.USD","SG9999015986.USD","IE00BJT1NW94.SGD"],"gpt_icon":0},{"id":"1192404482","title":"艾伯维将在2025年ASH大会上展示多个血癌新治疗方式的最新数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1192404482","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1192404482?lang=zh_cn&edition=full","pubTime":"2025-12-02 21:16","pubTimestamp":1764681374,"startTime":"0","endTime":"0","summary":"艾伯维将在2025年ASH大会上展示多个血癌新治疗方式的最新数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015978.USD","LU0965509101.SGD","LU2133065610.SGD","LU0289739699.SGD","LU1989771016.USD","LU0029864427.USD","LU1718418525.SGD","LU2089284900.SGD","LU0114720955.EUR","LU0553294199.USD","LU1057294990.SGD","LU0689472784.USD","LU2237443549.SGD","LU1989772923.USD","LU0234572021.USD","LU1037948541.HKD","IE00BN8TJ469.HKD","LU0882574055.USD","LU2112291526.USD","LU0256863902.USD","LU1839511570.USD","LU0417517546.SGD","LU1934455863.HKD","LU2023251221.USD","IE0009355771.USD","LU1732799900.SGD","BK4588","IE0002270589.USD","IE00BBT3K403.USD","LU2237443978.SGD","ABBV","LU1061106388.HKD","LU0661504455.SGD","LU0738911758.USD","LU1003077747.HKD","IE00B19Z3B42.SGD","LU2089984988.USD","LU1934455194.USD","LU1983299246.USD","LU0689626769.HKD","LU0943347566.SGD","SG9999015945.SGD","LU2087621335.USD","LU0310800379.SGD","LU1267930573.SGD","LU1037948897.HKD","LU0158827948.USD","LU0795875086.SGD","LU0965509283.SGD","IE00BVYPNV92.GBP","LU1023059063.AUD","LU1934455277.USD","LU0203345920.USD","BK4533","LU2129689605.HKD","BK4585","LU0128525929.USD","IE00BJJMRZ35.SGD","LU1267930490.SGD","SG9999003800.SGD","LU2129689514.USD","LU1496350171.SGD","LU0708994859.HKD","LU2237443465.HKD","LU0820561818.USD","BK4566","LU1244550577.SGD","LU1551013425.SGD","IE00BGHQF631.EUR","LU0456855351.SGD","LU2089283258.USD","IE00BJT1NW94.SGD","LU1585245621.USD","IE00BDGV0183.EUR","LU2347655156.SGD","SG9999015986.USD","LU1929549753.HKD","IE00BVYPNW00.USD","LU0949170772.SGD","BK4139","LU0820561909.HKD","LU0795875169.SGD","LU0122379950.USD","LU0432979614.USD","IE00B19Z3581.USD","LU1244550494.USD","LU0965508806.USD","LU0965509010.AUD","LU0545039389.USD","LU1551013342.USD","LU0985320562.USD","IE00BSNM7G36.USD","BK4559","LU1093756325.SGD","BK4581","LU2237443622.USD","LU1162221912.USD","IE00BFTCPJ56.SGD","LU2237443895.HKD","LU0256863811.USD","IE00B42XCP33.USD","LU1496350502.SGD","IE00B3PB1722.GBP","SG9999011175.SGD","LU0124676726.USD","LU1074936037.SGD","LU1989772840.SGD","BK4550","SG9999015952.SGD","IE00B4R5TH58.HKD","LU0861579265.USD","IE00BLSP4239.USD","LU1244550221.USD","LU0203347892.USD","LU1291159041.SGD","LU0198837287.USD","IE0004445239.USD","LU0234570918.USD","LU0320765646.SGD","LU2129689431.USD","LU1430594728.SGD","LU0170899867.USD","SG9999001440.SGD","LU0310799852.SGD","LU0912757837.SGD","LU2237443382.USD","BK4534","IE0002141913.USD","IE00BLSP4452.SGD","IE00B2B36J28.USD","LU2468319806.SGD","LU1732800096.USD","LU0211328371.USD","LU0211327993.USD","LU1093756168.USD","LU0058720904.USD"],"gpt_icon":0},{"id":"2586382780","title":"2026年前的价值猎场：哪些公司仍然被市场“误伤”？","url":"https://stock-news.laohu8.com/highlight/detail?id=2586382780","media":"金十数据","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586382780?lang=zh_cn&edition=full","pubTime":"2025-11-28 21:25","pubTimestamp":1764336300,"startTime":"0","endTime":"0","summary":"标普500指数今年上涨近16%，而涵盖30只成分股的道琼斯工业指数则攀升了11.5%。随着2026年逐步靠近，分析师利用CNBC Pro的股票筛选器，寻找那些可能被市场忽视的公司。伦敦证券交易所集团调查的分析师给出的共识目标价为90.66美元，这意味着较该股仍有超过10%的潜在上行空间。CVS在10月底公布的三季度盈利和营收均超预期，并因保险业务改善而上调了调整后利润展望。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-11-28/doc-infyypau9598541.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["DRAM","MDT","SH","OEX","LU2089284900.SGD","BK4550","BK4141","LU0056508442.USD","SPXU","LU2089984988.USD","LU1280957306.USD","LU2237443465.HKD","IVV","ABBV","LU1023059063.AUD","LU0882574055.USD","LU0162691827.USD","IE00BLSP4452.SGD","UPRO","LU0496365809.HKD","LU1989772840.SGD","SG9999011175.SGD","CVS","IE00BKVL7J92.USD","SDS","LU0861579265.USD","ESmain","LU0127658192.USD","IE00B19Z3581.USD","SSO","SG9999015945.SGD","LU2087621335.USD","LU0278409577.USD","LU2023251221.USD","BK4588","LU1061106388.HKD","LU0345781412.USD","IE00BZ1G4Q59.USD","LU0368265764.SGD","OEF","MU","MESmain",".SPX","LU0256863811.USD","LU1244550221.USD","VST","SPY","LU0274383776.USD","LU0661504455.SGD"],"gpt_icon":1},{"id":"1192255262","title":"Skyrizi®（Risankizumab）获得加拿大药品局对溃疡性结肠炎的积极报销推荐，艾伯维公司与泛加拿大药品联盟签署谅解备忘录","url":"https://stock-news.laohu8.com/highlight/detail?id=1192255262","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1192255262?lang=zh_cn&edition=full","pubTime":"2025-11-28 20:02","pubTimestamp":1764331338,"startTime":"0","endTime":"0","summary":"Skyrizi®（Risankizumab）获得加拿大药品局对溃疡性结肠炎的积极报销推荐，艾伯维公司与泛加拿大药品联盟签署谅解备忘录","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1551013342.USD","LU0211328371.USD","LU0738911758.USD","LU1839511570.USD","LU0289739699.SGD","IE00BJT1NW94.SGD","LU1093756325.SGD","IE00BLSP4239.USD","LU1732800096.USD","LU2237443382.USD","LU0553294199.USD","IE00B42XCP33.USD","SG9999011175.SGD","SG9999015952.SGD","LU1989772923.USD","IE00BBT3K403.USD","LU0029864427.USD","LU2347655156.SGD","BK4588","LU0417517546.SGD","SG9999015945.SGD","SG9999015986.USD","LU1003077747.HKD","IE00BFTCPJ56.SGD","IE00BVYPNW00.USD","IE00B2B36J28.USD","LU0203345920.USD","LU0689472784.USD","IE00BJJMRZ35.SGD","LU1496350171.SGD","LU0965508806.USD","IE00BSNM7G36.USD","LU0943347566.SGD","LU0170899867.USD","LU1934455863.HKD","IE00B3PB1722.GBP","LU0310800379.SGD","LU1244550494.USD","IE0002270589.USD","IE00BVYPNV92.GBP","IE00B19Z3B42.SGD","LU1037948541.HKD","LU2237443549.SGD","LU0256863902.USD","LU1934455277.USD","LU0820561818.USD","LU1037948897.HKD","LU0820561909.HKD","LU0432979614.USD","LU2087621335.USD","SG9999003800.SGD","IE00B19Z3581.USD","LU2133065610.SGD","LU2237443978.SGD","LU1934455194.USD","BK4534","LU2089284900.SGD","LU0912757837.SGD","BK4550","LU1267930573.SGD","LU1989772840.SGD","BK4566","IE00B4R5TH58.HKD","IE00BGHQF631.EUR","LU0211327993.USD","BK4533","IE0004445239.USD","LU0234570918.USD","LU0861579265.USD","LU0949170772.SGD","BK4139","IE00BLSP4452.SGD","LU1244550221.USD","LU1496350502.SGD","LU0661504455.SGD","LU0965509010.AUD","LU0965509283.SGD","LU1074936037.SGD","LU2089283258.USD","LU1267930490.SGD","LU2237443465.HKD","BK4581","LU2129689514.USD","IE00BN8TJ469.HKD","LU1732799900.SGD","LU1023059063.AUD","IE0002141913.USD","LU0882574055.USD","LU0122379950.USD","LU1989771016.USD","LU0234572021.USD","LU0795875169.SGD","LU1551013425.SGD","LU0320765646.SGD","LU0795875086.SGD","LU2237443895.HKD","LU2089984988.USD","LU1244550577.SGD","LU0158827948.USD","LU1585245621.USD","LU1061106388.HKD","LU2237443622.USD","LU1162221912.USD","LU1983299246.USD","LU0128525929.USD","LU1057294990.SGD","BK4559","LU1291159041.SGD","IE00BDGV0183.EUR","LU0689626769.HKD","LU0114720955.EUR","ABBV","LU0198837287.USD","SG9999001440.SGD","LU2129689605.HKD","SG9999015978.USD","LU0985320562.USD","LU0965509101.SGD","LU2112291526.USD","LU1093756168.USD","IE0009355771.USD","LU0708994859.HKD","BK4585","LU0058720904.USD","LU1430594728.SGD","LU0256863811.USD","LU0124676726.USD","LU2129689431.USD","LU1929549753.HKD","LU2468319806.SGD","LU2023251221.USD","LU0310799852.SGD","LU0545039389.USD","LU0456855351.SGD","LU0203347892.USD","LU1718418525.SGD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.abbvie.com","stockEarnings":[{"period":"1week","weight":0.0171},{"period":"1month","weight":-0.024},{"period":"3month","weight":0.0228},{"period":"6month","weight":0.1424},{"period":"1year","weight":0.2696},{"period":"ytd","weight":-0.024}],"compareEarnings":[{"period":"1week","weight":0.004},{"period":"1month","weight":0.0147},{"period":"3month","weight":0.0145},{"period":"6month","weight":0.113},{"period":"1year","weight":0.1437},{"period":"ytd","weight":0.0147}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"艾伯维公司注册成立于2012年4月10日，是一家全球性的、以研究为基础的生物制药公司。Abbvie公司从事开发和销售先进的疗法，来解决一些世界上最复杂和严重的疾病。Abbvie公司的产品主要集中在慢性自身免疫性疾病领域，包括类风湿性关节炎，牛皮癣和克罗恩病，银屑病和克罗恩病;低睾酮，HIV，子宫内膜异位症;甲状腺疾病;帕金森病;和并发症的慢性肾脏疾病和囊性纤维化相关的或其他健康问题。","yearOnYearQuotes":[{"month":1,"riseRate":0.357143,"avgChangeRate":-0.019222},{"month":2,"riseRate":0.846154,"avgChangeRate":0.038959},{"month":3,"riseRate":0.769231,"avgChangeRate":0.006022},{"month":4,"riseRate":0.615385,"avgChangeRate":0.009221},{"month":5,"riseRate":0.615385,"avgChangeRate":0.002163},{"month":6,"riseRate":0.461538,"avgChangeRate":0.008788},{"month":7,"riseRate":0.538462,"avgChangeRate":0.01232},{"month":8,"riseRate":0.538462,"avgChangeRate":0.007409},{"month":9,"riseRate":0.538462,"avgChangeRate":0.014941},{"month":10,"riseRate":0.615385,"avgChangeRate":0.007438},{"month":11,"riseRate":0.769231,"avgChangeRate":0.063841},{"month":12,"riseRate":0.692308,"avgChangeRate":0.025718}],"exchange":"NYSE","name":"艾伯维公司","nameEN":"AbbVie"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"艾伯维公司(ABBV)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供艾伯维公司(ABBV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"艾伯维公司,ABBV,艾伯维公司股票,艾伯维公司股票老虎,艾伯维公司股票老虎国际,艾伯维公司行情,艾伯维公司股票行情,艾伯维公司股价,艾伯维公司股市,艾伯维公司股票价格,艾伯维公司股票交易,艾伯维公司股票购买,艾伯维公司股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"艾伯维公司(ABBV)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供艾伯维公司(ABBV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}